In the complex journey of advanced prostate cancer, care doesn’t just happen in the clinic. It includes everyday emotional and practical challenges patients and families face. Social workers help bridge these gaps.

These scientifically advanced technologies may help transform millions of patients’ lives

Twenty-five years ago, Novartis pioneered a paradigm shift in cancer care with the introduction of the first tyrosine kinase inhibitor (TKI) for chronic myeloid leukemia (CML), transforming it from a deadly disease into a chronic condition for most patients. This breakthrough helped lay the foundation for targeted therapies in oncology and continues to shape the future of CML treatment today.

Thierry Diagana, California Sites Head at Novartis, shares the vision for a new research hub that will power future drug discovery.

Elevated Lp(a) is a unique and genetically determined condition that can increase risk for ASCVD¹.  Read on to learn more about patient populations at risk. 

In this interview, Reshema Kemps-Polanco shares her top career tips, the mindset that drives her, and the quote she still lives by today.